Health Care/Hospital

China Sky One Medical Reports Second Quarter 2007 Financial Results

HARBIN, China, Aug. 15 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic products in China, today announced financial results for the three month and six month periods endi...

2007-08-15 04:01 536

Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million

BEIJING and CLAREMONT, Calif., Aug. 15 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced that revenues for the second quarter of 2007 increased more than 35% over the first quarter of 2007 exceeding $1,872,000 and were 139 times revenu...

2007-08-15 02:07 440

WuXi PharmaTech Announces Closing of Initial Public Offering

SHANGHAI, China, Aug. 14 /Xinhua-PRENewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech"), the leading China-based pharmaceutical and biotechnology research and development outsourcing company in the growing global drug R&D outsourcing market, announced today the closing of i...

2007-08-15 09:14 729

China Holdings CEO to Speak at the Asia Bulk Liquid Storage, Transportation and Terminals Conference

Conference to be Held on August 29-31, 2007 in Singapore LAS VEGAS and BEIJING, Aug. 14 /Xinhua-PRNewswire-FirstCall/ -- China Holdings, Inc. (OTC Bulletin Board: CHHL), a development stage company with the goal of becoming a leading diversified global asset holding company and engaged in mul...

2007-08-14 21:38 528

China Medicine Announces Second Quarter 2007 Results

GUANGZHOU, China, Aug. 14 /Xinhua-PRNewswire-FirstCall/ -- Second Quarter Highlights: -- Revenue increased 105% to $8.3 million -- Operating income increased 313% to $1.4 million -- Net Income increased 328% to $1.1 million or $0.08 per diluted share -- First six ...

2007-08-14 22:19 601

Sinovac Commences Vaccination of Volunteers for the Clinical Research of Pandemic Influenza Vaccine (H5N1)

BEIJING, Aug. 14 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a China-based biopharmaceutical company focusing on vaccine development, today announced that it has commenced vaccination of volunteers for the clinical research of Pandemic Influenza Vaccine (H5N1), which is the continue...

2007-08-14 20:00 924

China Pharma Holdings, Inc. Announces Record Second Quarter 2007 Results

HAIKOU CITY, Hainan Province, China, Aug. 14 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), a specialty bio-pharmaceutical company that develops, manufactures and markets Western and Chinese medicines, today announced its financial resul...

2007-08-14 20:30 676

Tiens Biotech Group (USA) Reports Second Quarter Results

NEW YORK, Aug. 14 /Xinhua-PRNewswire-FirstCall/ -- Tiens Biotech Group (USA), Inc. (“the Company” or “Tiens”), (Amex: TBV), http://www.tiens-bio.com , announced financial results for the second quarter ended June 30, 2007. Revenue for both the second quarter of 2007 and the second quart...

2007-08-14 20:00 675

Sundia in Top 200 for 'Red Herring 100 Asia' Awards 2007

SAN FRANCISCO, Aug. 13 /Xinhua-PRNewswire/ -- Red Herring Magazine announced on 8/7 that Sundia MediTech (Shanghai) Company has been short listed forerunners of the Red Herring 100 Asia 2007 awards. The 100 winners will be announced at the Red Herring 100 Asia event in Hong Kong, on August 29-31...

2007-08-13 21:27 533

WuXi PharmaTech (NYSE: WX) Fills Three Senior Level Positions

SHANGHAI, China, Aug. 13 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's premier provider of pharmaceutical R&D outsourcing services announced today the addition of three key senior level positions. These positions include Executive Vice President of Operations, Vice President o...

2007-08-13 20:09 971

Skystar Bio-Pharmaceutical Announces Conference Call to Discuss

XI'AN, China, Aug. 13 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar" or the "Company") today announced that it will conduct a conference call at 10:00 a.m. Eastern Time on Wednesday, August 15, 2007 to discuss the second quarter ...

2007-08-13 19:00 553

China-Biotics, Inc. Reports First Quarter 2008 Financial Results

SHANGHAI, China, Aug. 13 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced its financi...

2007-08-13 20:00 706

Sinovac Schedules First Half 2007 Financial Results Date

BEIJING, Aug. 13 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release financial results for the six months ended June 30, 2007 before the market opens on Thursday, August 16, 2007 with an acco...

2007-08-13 20:00 643

China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results

SHANGHAI, China, Aug. 10 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT), a leading Chinese firm specializing in the research, development, manufacture, marketing and distribution of probiotics dietary supplements, today announced it will conduct a conference call...

2007-08-10 22:00 569

Winner Medical Group Reports 19% Increase in Net Sales for Third Quarter Fiscal 2007

SHENZHEN, China, Aug. 10 /Xinhua-PRNewswire/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG), today reported consolidated financial results for the third quarter and nine months ending June 30, 2007 for fiscal year 2007. Third Quarter Results Consolidated third quarter net s...

2007-08-10 20:30 728

TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)

TAIPEI, Taiwan, Aug.10 /Xinhua-PRNewswire/ -- TaiGen Biotechnology Inc. announces the successful completion of patient recruitment for the global double-blind Phase II clinical trial of Nemonoxacin (TG-873870) for the treatment of adult community-acquired pneumonia (CAP). A total of 265 patie...

2007-08-10 12:30 484

China Pharma Holdings, Inc. Announces Conference Call to Discuss Second Quarter 2007 Results

HAIKOU CITY, China, Aug. 9 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) today announced that the Company will host a conference call at 11:00 am EST on Tuesday, August 14, 2007, to discuss results for the second quarter of 2007. Jo...

2007-08-09 20:30 712

WuXi PharmaTech (Cayman) Inc. Announces Pricing of Initial Public Offering on NYSE

SHANGHAI, China, Aug. 8 /Xinhua-PRNewswire-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) (“WuXi PharmaTech”), a leading China-based pharmaceutical and biotechnology research and development outsourcing company in the growing global drug R&D outsourcing market, announced today that i...

2007-08-09 10:44 681

3SBio Inc. Announces Second Quarter 2007 Results

SHENYANG, China, Aug. 9 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the second quarter ended June 30, ...

2007-08-09 04:11 668

Bend Research and Pfizer Offer Proprietary Technology to Help Solve Drug-Discovery Challenges

New Partners Invited To Use Spray-Dried Dispersion (SDD) Technology To Overcome Problems of Low Solubility BEND, Ore., Aug. 9 /Xinhua-PRNewswire/ -- Bend Research Inc. today announced a new initiative to make available Pfizer's drug-delivery technology for improving the clinical value of ...

2007-08-09 11:49 739
1 ... 722723724725726727728 ... 740